The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 28, 2023
Filed:
Oct. 15, 2020
Applicant:
Cipla Limited, Mumbai, IN;
Inventors:
Geena Malhotra, Mumbai, IN;
Kalpana Joshi, Thane, IN;
Jeevan Ghosalkar, Thane, IN;
Preeti Raut, Mumbai, IN;
Assignee:
CIPLA LIMITED, Mumbai, IN;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/685 (2006.01); A61K 45/06 (2006.01); A61K 31/675 (2006.01); A61K 31/34 (2006.01); A61K 31/4525 (2006.01); A61K 31/47 (2006.01); A61K 31/506 (2006.01); A61K 31/5365 (2006.01); A61K 31/635 (2006.01); A61K 9/24 (2006.01); A61K 47/22 (2006.01); A61K 9/20 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/685 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61K 9/209 (2013.01); A61K 9/2013 (2013.01); A61K 31/34 (2013.01); A61K 31/4525 (2013.01); A61K 31/47 (2013.01); A61K 31/506 (2013.01); A61K 31/5365 (2013.01); A61K 31/635 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); A61K 47/22 (2013.01);
Abstract
An oral or injectable pharmaceutical composition is provided for treating diseases caused by retroviruses or hepatitis B viruses. The composition comprises a therapeutically effective amount of at least one anti-retroviral drug and a therapeutically effective amount of at least one pharmacokinetic booster or enhancer or derivative thereof. Methods and kits are also provided.